Expression of ERG protein in prostate cancer: variability and biological correlates.
about
Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.Intrafocal heterogeneity of ERG protein expression and gene fusion pattern in prostate cancer.Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion.Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN.
P2860
Expression of ERG protein in prostate cancer: variability and biological correlates.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Expression of ERG protein in prostate cancer: variability and biological correlates.
@ast
Expression of ERG protein in prostate cancer: variability and biological correlates.
@en
type
label
Expression of ERG protein in prostate cancer: variability and biological correlates.
@ast
Expression of ERG protein in prostate cancer: variability and biological correlates.
@en
prefLabel
Expression of ERG protein in prostate cancer: variability and biological correlates.
@ast
Expression of ERG protein in prostate cancer: variability and biological correlates.
@en
P2093
P2860
P356
P1476
Expression of ERG protein in prostate cancer: variability and biological correlates.
@en
P2093
Anna Frolov
Deyali Chatterjee
Gustavo Ayala
Michael Ittmann
Susan Hilsenbeck
P2860
P304
P356
10.1530/ERC-14-0586
P577
2015-06-01T00:00:00Z